CHELMSFORD, Mass.--(BUSINESS WIRE)--Triton BioSystems, Inc. (TBS), announced today it has hired Dr. Donald S. Masters as its President and CEO effective immediately. An early stage biotechnology company, TBS is developing promising targeted nanotherapeutic products for the treatment of cancer. Dr. Masters brings over 27 years experience in the biotechnology field, most recently as CEO of Esperance Pharmaceuticals of Baton Rouge, LA.
